| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Autobiography |
| Article Title |
Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kumi Ishida, Takuya Inoue, Kaori Fujiwara, Taisuke Sakanaka, Ken Narabayashi, Sadaharu Nouda, Toshihiko Okada, Kazuki Kakimoto, Takanori Kuramoto, Ken Kawakami, Yosuke Abe, Toshihisa Takeuchi, Mitsuyuki Murano, Satoshi Tokioka, Eiji Umegaki and Kazuhide Higuchi |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Takuya Inoue, MD, PhD, the Second Department of Internal Medicine, Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan. ureuretakuwan@yahoo.co.jp
|
| Key Words |
Crohn's disease; Adalimumab; Immunomodulator; Azathioprine; Inflammatory bowel disease |
| Core Tip |
In this study, the authors found that adalimumab (ADA) treatment with concomitant azathioprine usage significantly suppressed the Crohn's disease activity index and increased the remission rate at 24 wk after the initiation of therapy, compared with ADA treatment alone.
|
| Publish Date |
2013-05-07 10:53 |
| Citation |
Ishida K, Inoue T, Fujiwara K, Sakanaka T, Narabayashi K, Nouda S, Okada T, Kakimoto K, Kuramoto T, Kawakami K, Abe Y, Takeuchi T, Murano M, Tokioka S, Umegaki E, Higuchi K. Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn’s disease patients. World J Gastroenterol 2013; 19(17): 2676-2682 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i17/2676.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i17.2676 |
